CN116076638A - A kind of preparation method and product thereof of probiotic fermented bayberry beverage - Google Patents
A kind of preparation method and product thereof of probiotic fermented bayberry beverage Download PDFInfo
- Publication number
- CN116076638A CN116076638A CN202211149768.6A CN202211149768A CN116076638A CN 116076638 A CN116076638 A CN 116076638A CN 202211149768 A CN202211149768 A CN 202211149768A CN 116076638 A CN116076638 A CN 116076638A
- Authority
- CN
- China
- Prior art keywords
- waxberry
- strain
- steps
- liquid
- following
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 42
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 42
- 235000013361 beverage Nutrition 0.000 title claims abstract description 28
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 235000009134 Myrica cerifera Nutrition 0.000 title claims description 71
- 244000061457 Solanum nigrum Species 0.000 title description 53
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 42
- 239000007788 liquid Substances 0.000 claims abstract description 34
- 238000000855 fermentation Methods 0.000 claims abstract description 22
- 230000004151 fermentation Effects 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 15
- 238000011081 inoculation Methods 0.000 claims abstract 4
- 235000021552 granulated sugar Nutrition 0.000 claims abstract 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 37
- 239000001963 growth medium Substances 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 21
- 230000003321 amplification Effects 0.000 claims description 18
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 18
- 230000001954 sterilising effect Effects 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 235000000346 sugar Nutrition 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 7
- 108010080698 Peptones Proteins 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 7
- 229940041514 candida albicans extract Drugs 0.000 claims description 7
- 235000019319 peptone Nutrition 0.000 claims description 7
- 239000012138 yeast extract Substances 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 5
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 240000001929 Lactobacillus brevis Species 0.000 claims description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- 235000015278 beef Nutrition 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 claims description 2
- 244000269152 Myrica pensylvanica Species 0.000 claims 18
- 235000007270 Gaultheria hispida Nutrition 0.000 claims 16
- 235000012851 Myrica pensylvanica Nutrition 0.000 claims 16
- 241000235342 Saccharomycetes Species 0.000 claims 6
- 238000001035 drying Methods 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 235000019640 taste Nutrition 0.000 abstract description 10
- 239000000796 flavoring agent Substances 0.000 abstract description 8
- 235000019634 flavors Nutrition 0.000 abstract description 8
- 229930006000 Sucrose Natural products 0.000 abstract description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 238000003860 storage Methods 0.000 abstract description 2
- 244000132436 Myrica rubra Species 0.000 abstract 6
- 239000002054 inoculum Substances 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 150000004666 short chain fatty acids Chemical class 0.000 description 12
- 235000021391 short chain fatty acids Nutrition 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 5
- 108010053775 Nisin Proteins 0.000 description 5
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000004309 nisin Substances 0.000 description 5
- 235000010297 nisin Nutrition 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108010062877 Bacteriocins Proteins 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000890668 Homo sapiens Free fatty acid receptor 2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 230000005800 cardiovascular problem Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B70/00—Preservation of non-alcoholic beverages
- A23B70/10—Preservation of non-alcoholic beverages by addition of preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/24—Lactobacillus brevis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明提供一种益生菌发酵杨梅饮料的制备方法及其产品,步骤如下:步骤1、将杨梅洗净,阴干后置于发酵桶中,加入白砂糖进行浸渍1‑2周,得到杨梅糖渍汁;其中白砂糖和杨梅的质量比为1:1;步骤2、往杨梅糖渍汁中加入适量的水,分别按杨梅体积的10%接种量接种酵母菌菌液A、10%接种量接种酵母菌菌液B,以及10%接种量接种益生菌菌液;步骤3、在10‑38℃下,发酵15天~20天,得发酵液;步骤4、将发酵液过滤后,即得产品。本发明生产流程更简单、成本更低,制备得到的产品能够产生多层次的芳香和口感,风味口感更佳,同时还具有营养价值高、保存期长的优点。
The invention provides a preparation method of a probiotic fermented red bayberry beverage and its product. The steps are as follows: step 1, wash the red bayberry, dry it in the shade, place it in a fermentation barrel, add white sugar and soak it for 1-2 weeks, and obtain red bayberry candied Juice; wherein the mass ratio of white granulated sugar and red bayberry is 1:1; Step 2, add an appropriate amount of water to red bayberry candied juice, inoculate yeast liquid A, 10% inoculum by 10% inoculation amount of red bayberry volume respectively Yeast liquid B, and 10% inoculum to inoculate the probiotic liquid; step 3, ferment at 10‑38°C for 15 to 20 days to obtain the fermentation liquid; step 4, filter the fermentation liquid to obtain the product . The production process of the invention is simpler and the cost is lower, and the prepared product can produce multi-layered aroma and taste, better flavor and taste, and also has the advantages of high nutritional value and long storage period.
Description
【技术领域】[Technical field]
本发明涉及一种益生菌发酵杨梅饮料的制备方法及其产品。The invention relates to a preparation method of a probiotic fermented bayberry beverage and the product thereof.
【背景技术】[Background technology]
杨梅果肉的含糖量为12%~13%,含酸量为0.5%~1.1%,富含纤维素、矿质元素、维生素和一定量的蛋白质、脂肪、果胶及8种对人体有益的胺基酸,其果实中钙、磷、铁含量要高出其他水果10多倍。具体的,每100克杨梅可食部的营养素含量:水分83.4-92.0克、热量28千卡,蛋白质0.8克,脂肪0.2克,碳水化合物5.7克,膳食纤维1克,果汁含糖量12-13克,含酸量0.5-1.8克,硫胺素10微克,核黄素50微克,烟酸0.3毫克,视黄醇当量92微克,胡萝卜素0.3微克,维生素A7微克,维生素C9毫克,维生素E0.81毫克,钙14毫克,镁10毫克,铁1毫克,锰0.72毫克,锌0.14毫克,铜20微克,钾149毫克,磷8毫克,钠0.7毫克,硒0.31微克。The sugar content of bayberry pulp is 12% to 13%, and the acid content is 0.5% to 1.1%. It is rich in cellulose, mineral elements, vitamins, a certain amount of protein, fat, pectin and 8 kinds of amino acids that are beneficial to the human body. The calcium, phosphorus and iron content in the fruit is more than 10 times higher than that of other fruits. Specifically, the nutrient content of every 100 grams of edible part of bayberry is: 83.4-92.0 grams of water, 28 kcal of calories, 0.8 grams of protein, 0.2 grams of fat, 5.7 grams of carbohydrates, 1 gram of dietary fiber, 12-13 grams of juice sugar content, 0.5-1.8 grams of acid content, 10 micrograms of thiamine, 50 micrograms of riboflavin, 0.3 milligrams of niacin, 92 micrograms of retinol equivalent, 0.3 micrograms of carotene, 7 micrograms of vitamin A, 9 milligrams of vitamin C, 0.81 milligrams of vitamin E, 14 milligrams of calcium, 10 milligrams of magnesium, 1 milligram of iron, 0.72 milligrams of manganese, 0.14 milligrams of zinc, 20 micrograms of copper, 149 milligrams of potassium, 8 milligrams of phosphorus, 0.7 milligrams of sodium, and 0.31 micrograms of selenium.
中医药认为:杨梅有生津止渴、健脾开胃之功效,多食不仅无伤脾胃,且有解毒祛寒之功效。《本草纲目》记载,「杨梅可止渴、和五脏、能涤肠胃、除烦愦恶气。」杨梅性平、无毒,具有消食、除湿、解暑、生津止咳、助消化、御寒、止泻、利尿、防治霍乱等医药功能等多种功能,有「果中玛瑙」之誉。因为杨梅具有消食、御寒、消暑、止泻、利尿、治痢疾以及生津上渴、清肠胃、除烦愤恶气等多种药用价值,我国的医学界对此有较高评价。Traditional Chinese medicine believes that bayberry has the effects of promoting the production of body fluids and quenching thirst, strengthening the spleen and stimulating appetite. Eating more bayberry not only does not hurt the spleen and stomach, but also has the effect of detoxifying and removing cold. "Compendium of Materia Medica" records that "bayberry can quench thirst, harmonize the five internal organs, cleanse the stomach and intestines, and remove irritability and bad air." Bayberry is mild and non-toxic. It has many functions such as digestion, dehumidification, heat relief, promoting the production of body fluids and relieving coughs, aiding digestion, keeping out the cold, stopping diarrhea, diuresis, and preventing and treating cholera. It is known as the "agate among fruits". Because bayberry has many medicinal values such as digestion, keeping out the cold, relieving the heat, stopping diarrhea, diuresis, treating dysentery, promoting the production of body fluids and thirst, cleaning the stomach and intestines, and removing irritability and bad air, the medical community in my country has a high evaluation of it.
杨梅含有多种有机酸以及丰富的维生素C,鲜果不易保存,可制成杨梅饮料。市面上的制造流程:杨梅清洗,加3%的盐及水,浸泡15分钟后,加糖、加水(10Kg杨梅加4Kg糖、1公升水);然后加热65℃下蒸煮10分钟,再浸渍15小时后过滤;继续加水调整糖度为14~16Brix、加柠檬酸调整酸度为0.7%,最后加热90度、热充填、90度杀菌5分钟,即得成品,并置于冰箱保鲜保存。因此,现有市面上生产方式存在以下缺点:Bayberry contains a variety of organic acids and rich vitamin C. Fresh fruit is not easy to preserve, so it can be made into bayberry beverage. The manufacturing process on the market is: wash the bayberry, add 3% salt and water, soak for 15 minutes, add sugar and water (10kg bayberry plus 4kg sugar and 1 liter of water); then heat and cook at 65℃ for 10 minutes, and filter after soaking for 15 hours; continue to add water to adjust the sugar content to 14-16 Brix, add citric acid to adjust the acidity to 0.7%, and finally heat to 90 degrees, hot fill, and sterilize at 90 degrees for 5 minutes to obtain the finished product, and place it in the refrigerator for fresh storage. Therefore, the existing production methods on the market have the following disadvantages:
1、生产步骤多、过程繁复;2、因为多次加热,破坏杨梅天然的酵素;3、必须经过多次蒸煮,浪费能源;4、必须添加食品添加物,柠檬酸;成品需要冰箱保鲜,运输保存麻烦成本高,而且保存期短(保鲜保存1~3个月)。1. There are many production steps and the process is complicated; 2. The natural enzymes of bayberry are destroyed due to repeated heating; 3. It must be steamed many times, which wastes energy; 4. Food additives and citric acid must be added; the finished product needs to be kept in the refrigerator, which is troublesome and costly to transport and store, and has a short shelf life (1 to 3 months).
【发明内容】[Summary of the invention]
本发明要解决的技术问题,在于提供一种益生菌发酵杨梅饮料的制备方法及其产品,其生产流程更简单、成本更低,制备得到的产品能够产生多层次的芳香和口感,风味口感更佳,同时还具有营养价值高、保存期长的优点。The technical problem to be solved by the present invention is to provide a preparation method of a probiotic fermented bayberry beverage and its product, the production process of which is simpler and the cost is lower. The prepared product can produce multi-level aroma and taste, and has better flavor and taste. It also has the advantages of high nutritional value and long shelf life.
本发明是这样实现的:The present invention is achieved in that:
一种益生菌发酵杨梅饮料的制备方法,所述方法步骤如下:A method for preparing a probiotic fermented bayberry beverage, the method comprising the following steps:
步骤1、将杨梅洗净,阴干后置于发酵桶中,加入白砂糖进行浸渍1-2周,得到杨梅糖渍汁;其中白砂糖和杨梅的质量比为1:1;Step 1, wash the bayberry, dry it in the shade, place it in a fermentation barrel, add white sugar and soak it for 1-2 weeks to obtain bayberry candied juice; wherein the mass ratio of white sugar to bayberry is 1:1;
步骤2、往杨梅糖渍汁中加入适量的水,分别按杨梅体积的10%接种量接种酵母菌菌液A、10%接种量接种酵母菌菌液B,以及10%接种量接种益生菌菌液;Step 2, adding an appropriate amount of water to the bayberry candied juice, and inoculating 10% of the volume of the bayberry with yeast solution A, 10% of the volume of the bayberry with yeast solution B, and 10% of the volume of the probiotic solution;
步骤3、在10-38℃下,发酵15天~20天,得发酵液;Step 3, fermenting at 10-38°C for 15-20 days to obtain a fermentation liquid;
步骤4、将发酵液过滤后,即得产品;Step 4: Filter the fermentation liquid to obtain the product;
所述酵母菌菌液A制备过程如下:The preparation process of the yeast liquid A is as follows:
(1)活化菌株:将酵母菌(Saccharomyces cerevisiae)BCRC 20581接种于培养基YM Broth中,24±2℃活化培养24-32h,制得活化菌株;(1) Activation of strain: Inoculate yeast (Saccharomyces cerevisiae) BCRC 20581 into the culture medium YM Broth and activate and culture at 24±2°C for 24-32 hours to obtain an activated strain;
(2)菌种一次放大:将活化后的菌株接种于新的培养基YM Broth中,在24±2℃培养10-16h,得一次放大菌液;(2) Primary amplification of strains: inoculate the activated strain into a new culture medium, YM Broth, and culture at 24±2°C for 10-16 h to obtain a primary amplification bacterial solution;
(3)菌种二次放大:将一次放大菌液接种于第一培养基中,于24±2℃培养10-16h,得酵母菌菌液A;所述第一培养基中:杨梅糖渍汁250ml、水1L,且杨梅糖渍汁的制备方法与步骤1相同;(3) Secondary amplification of the strain: inoculate the first amplified bacterial solution into the first culture medium, and culture at 24±2° C. for 10-16 h to obtain yeast culture solution A; the first culture medium contains: 250 ml of bayberry candied juice and 1 L of water, and the preparation method of the bayberry candied juice is the same as step 1;
所述酵母菌菌液B制备过程如下:The preparation process of the yeast liquid B is as follows:
(1)活化菌株:将酵母菌(Saccharomyces cerevisiae)BCRC 21967接种于培养基YPD Broth中,24±2℃活化培养24-32h,制得活化菌株;(1) Activation of strains: Inoculate yeast (Saccharomyces cerevisiae) BCRC 21967 into YPD Broth medium and activate and culture at 24±2°C for 24-32 hours to obtain an activated strain;
(2)菌种一次放大:将活化后的菌株接种于新的培养基YPD Broth,在24±2℃培养10-16h,得一次放大菌液;(2) Primary amplification of strains: inoculate the activated strain into a new culture medium, YPD Broth, and culture at 24±2℃ for 10-16h to obtain a primary amplification bacterial solution;
(3)菌种二次放大:将一次放大菌液接种于第一培养基中,于24±2℃培养10-16h,得酵母菌菌液B;(3) Secondary amplification of the strain: inoculate the first amplified bacterial solution into the first culture medium and culture at 24±2°C for 10-16 h to obtain yeast culture solution B;
益生菌菌液制备过程如下:The preparation process of probiotic liquid is as follows:
(1)活化菌株:将益生菌菌株嗜酸乳杆菌、保加利亚乳杆菌、德氏乳杆菌亚种、罗伊氏乳杆菌、短乳杆菌、干酪乳杆菌以及发酵乳杆菌分别接种于第二培养基中,在37±2℃活化培养36-48h,制得活化菌株;(1) Activating strains: Probiotic strains Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus delbrueckii subsp., Lactobacillus reuteri, Lactobacillus brevis, Lactobacillus casei and Lactobacillus fermentum are inoculated into a second culture medium, respectively, and activated and cultured at 37±2° C. for 36-48 hours to obtain activated strains;
(2)菌种放大:将7种活化后的菌株混合后接种于第一培养基中,在37±2℃放大培养18-24h,得益生菌菌液。(2) Strain amplification: The seven activated strains were mixed and inoculated into the first culture medium, and cultured at 37±2°C for 18-24 hours to obtain a probiotic bacterial liquid.
进一步地,所述方法还包括灭菌,即将发酵液过滤后进行灭菌,即得产品;所述灭菌方法如下:Furthermore, the method further comprises sterilization, that is, the fermentation liquid is filtered and then sterilized to obtain the product; the sterilization method is as follows:
将滤液在137±5℃超高温下瞬间灭菌15秒后,利用利乐包进行包装,即得成品。The filtrate is sterilized at ultra-high temperature of 137±5℃ for 15 seconds and then packaged in Tetra Pak to obtain the finished product.
进一步地,所述方法还包括灭菌,所述灭菌方法如下:Furthermore, the method further comprises sterilization, and the sterilization method is as follows:
将滤液在低温85℃灭菌45分钟,再充填进易拉罐内,然后置于高温高压杀菌釜中,115±5℃下灭菌15分钟,即得成品。The filtrate is sterilized at a low temperature of 85°C for 45 minutes, filled into cans, and then placed in a high temperature and high pressure sterilizer, sterilized at 115±5°C for 15 minutes to obtain the finished product.
进一步地,所述步骤2中添加的水量与杨梅的质量比为2:1。Furthermore, the mass ratio of the water added in step 2 to the bayberry is 2:1.
进一步地,所所述培养基YM Broth中:酵母菌提取物3.0g、麦芽糖3.0g、蛋白胨5.0g、葡萄糖10.0g以及水1L;Furthermore, the medium YM Broth contains: 3.0 g yeast extract, 3.0 g maltose, 5.0 g peptone, 10.0 g glucose and 1 L water;
所述培养基YPD Broth中:酵母菌提取物10.0g、麦芽糖3.0g、蛋白胨20.0g、葡萄糖20.0g以及水1L。The culture medium YPD Broth contains: 10.0 g of yeast extract, 3.0 g of maltose, 20.0 g of peptone, 20.0 g of glucose and 1 L of water.
进一步地,所述第二培养基中:蛋白酶蛋白胨3号10.0g,牛肉浸膏10.0g,酵母提取物5.0g,葡萄糖20.0g,吐温80 1.0g,柠檬酸铵2.0g,CH3COONa 5.0g,MgSO4·7H2O 0.1g,MnSO4·H2O 0.05g,K2HPO42.0g,水1.0L;调整pH值至6.2-6.5。Furthermore, the second culture medium contains: 10.0 g of protease peptone No. 3, 10.0 g of beef extract, 5.0 g of yeast extract, 20.0 g of glucose, 1.0 g of Tween 80, 2.0 g of ammonium citrate, 5.0 g of CH 3 COONa, 0.1 g of MgSO 4 ·7H 2 O, 0.05 g of MnSO 4 ·H 2 O, 2.0 g of K 2 HPO 4 , and 1.0 L of water; and the pH value is adjusted to 6.2-6.5.
进一步地,所述第二培养基中还包括琼脂粉每升15.0克。Furthermore, the second culture medium also includes 15.0 grams per liter of agar powder.
进一步地,根据上述一种益生菌发酵杨梅饮料的制备方法,制备得到的杨梅饮料。Furthermore, according to the above-mentioned method for preparing a probiotic fermented bayberry beverage, a bayberry beverage is prepared.
本发明具有如下优点:The present invention has the following advantages:
本发明采用二株酵母菌BCRC20581和酵母菌BCRC21967(GRAS菌种)协同采用七株益生菌发酵杨梅饮料有以下优点:含有丰富维生素B群及各种维生素,以及活性抗氧化酵素;产生多种胺基酸,包括离胺酸、异白胺酸、苯丙胺酸、酪胺酸、色胺酸;多种酵母菌的应用能够产生多层次的芳香和口感,具有提升香气、香味的效果,使得产品口感佳而且有层次感。The present invention adopts two yeast strains BCRC20581 and yeast strain BCRC21967 (GRAS strains) to cooperate with seven probiotic strains to ferment the bayberry beverage, which has the following advantages: it contains rich B vitamins and various vitamins, as well as active antioxidant enzymes; it produces a variety of amino acids, including lysine, isoleucine, phenylalanine, tyrosine, and tryptophan; the application of a variety of yeasts can produce multi-level aromas and tastes, has the effect of enhancing aroma and flavor, and makes the product taste good and have a sense of hierarchy.
同时,能产生酵素、乳酸、有机酸、短链脂肪酸、寡糖、益生源,消化酵素;能产生天然抑菌素罗伊氏素、乳酸链球菌素,可抑制坏菌,提升产品保存期(灭菌情况下可保存1-5年,不灭菌情况下可保存10-15年);其中嗜酸乳杆菌和罗伊氏乳杆菌能抑制幽门杆菌;提高总多酚、总类黄酮含量,提供更多营养保健成分;维持人体正常的肠道菌相,预防肠胃道疾病,改善大肠急躁症候群症状,预防结肠炎;具有免疫调节作用:缓和食物过敏现象,改善遗传性过敏疾病症状,预防幼儿过敏;具有代谢作用:降低结肠癌发生几率,缓和乳糖不耐症以及降低胆固醇、降低血压。At the same time, it can produce enzymes, lactic acid, organic acids, short-chain fatty acids, oligosaccharides, prebiotics, and digestive enzymes; it can produce natural antibacterial agents such as reuteri and nisin, which can inhibit bad bacteria and increase the shelf life of the product (it can be stored for 1-5 years under sterilization and 10-15 years under non-sterilization); among them, Lactobacillus acidophilus and Lactobacillus reuteri can inhibit Helicobacter pylori; it increases the content of total polyphenols and total flavonoids, and provides more nutritional and health care ingredients; it maintains normal intestinal flora of the human body, prevents gastrointestinal diseases, improves the symptoms of irritable bowel syndrome, and prevents colitis; it has an immunomodulatory effect: it alleviates food allergies, improves the symptoms of hereditary allergic diseases, and prevents allergies in young children; it has a metabolic effect: it reduces the incidence of colon cancer, alleviates lactose intolerance, and lowers cholesterol and blood pressure.
总之,本发明生产出来的益生菌发酵杨梅饮料,因为有天然乳酸菌细菌素的抑菌、抗菌能力保护,不经杀菌处理,可以永久保存、且能保留活菌和酵素;也可以经杀菌处理,能保存1-5年,且不影响风味和口感。本发明使用的二株酵母菌和七株益生菌皆为WHO认证的GRAS菌种,符合食品安全要求。In summary, the probiotic fermented bayberry beverage produced by the present invention can be permanently stored without sterilization treatment, and can retain live bacteria and enzymes because of the antibacterial and antibacterial ability protection of natural lactic acid bacteria bacteriocins; it can also be sterilized and stored for 1-5 years without affecting the flavor and taste. The two yeast strains and seven probiotic strains used in the present invention are all GRAS strains certified by WHO, meeting food safety requirements.
【附图说明】【Brief Description of the Drawings】
下面参照附图结合实施例对本发明作进一步的说明。The present invention will be further described below in conjunction with embodiments with reference to the accompanying drawings.
图1为本发明一种益生菌发酵杨梅饮料的制备方法的制备流程图。FIG. 1 is a preparation flow chart of a method for preparing a probiotic fermented bayberry beverage of the present invention.
【具体实施方式】[Specific implementation method]
下面将结合附图1和具体实施方式对本发明的技术方案进行清楚、完整地描述。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。The technical solution of the present invention will be clearly and completely described below in conjunction with Figure 1 and the specific implementation methods. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without creative work are within the scope of protection of the present invention. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
本发明涉及一种益生菌发酵杨梅饮料的制备方法,所述方法步骤如下:The present invention relates to a method for preparing a probiotic fermented bayberry beverage, the method comprising the following steps:
步骤1、将杨梅洗净,阴干后置于发酵桶中,加入白砂糖进行浸渍1-2周,得到杨梅糖渍汁;其中白砂糖和杨梅的质量比为1:1;Step 1, wash the bayberry, dry it in the shade, place it in a fermentation barrel, add white sugar and soak it for 1-2 weeks to obtain bayberry candied juice; wherein the mass ratio of white sugar to bayberry is 1:1;
步骤2、往杨梅糖渍汁中加入适量的水,添加的水量与杨梅的质量比为2:1;分别按杨梅体积的10%接种量接种酵母菌菌液A、10%接种量接种酵母菌菌液B,以及10%接种量接种益生菌菌液;Step 2, adding an appropriate amount of water to the bayberry candied juice, with the mass ratio of the added water to the bayberry being 2:1; inoculating 10% of the volume of the bayberry with yeast solution A, 10% with yeast solution B, and 10% with probiotic solution;
步骤3、在10-38℃下,发酵15天~20天,得发酵液;Step 3, fermenting at 10-38°C for 15-20 days to obtain a fermentation liquid;
步骤4、将发酵液过滤后,即得产品;Step 4: Filter the fermentation liquid to obtain the product;
所述酵母菌菌液A制备过程如下:The preparation process of the yeast liquid A is as follows:
(1)活化菌株:将酵母菌(Saccharomyces cerevisiae)BCRC 20581接种于培养基YM Broth中,24±2℃活化培养24-32h,制得活化菌株;(1) Activation of strain: Inoculate yeast (Saccharomyces cerevisiae) BCRC 20581 into the culture medium YM Broth and activate and culture at 24±2°C for 24-32 hours to obtain an activated strain;
(2)菌种一次放大:将活化后的菌株接种于新的培养基YM Broth中,在24±2℃培养10-16h,得一次放大菌液;(2) Primary amplification of strains: inoculate the activated strain into a new culture medium, YM Broth, and culture at 24±2°C for 10-16 h to obtain a primary amplification bacterial solution;
(3)菌种二次放大:将一次放大菌液接种于第一培养基中,于24±2℃培养10-16h,得酵母菌菌液A;所述第一培养基中:杨梅糖渍汁250ml、水1L,且杨梅糖渍汁的制备方法与步骤1相同;(3) Secondary amplification of the strain: inoculate the first amplified bacterial solution into the first culture medium, and culture at 24±2° C. for 10-16 h to obtain yeast culture solution A; the first culture medium contains: 250 ml of bayberry candied juice and 1 L of water, and the preparation method of the bayberry candied juice is the same as step 1;
所述酵母菌菌液B制备过程如下:The preparation process of the yeast liquid B is as follows:
(1)活化菌株:将酵母菌(Saccharomyces cerevisiae)BCRC 21967接种于培养基YPD Broth中,24±2℃活化培养24-32h,制得活化菌株;(1) Activation of strains: Inoculate yeast (Saccharomyces cerevisiae) BCRC 21967 into YPD Broth medium and activate and culture at 24±2°C for 24-32 hours to obtain an activated strain;
(2)菌种一次放大:将活化后的菌株接种于新的培养基YPD Broth,在24±2℃培养10-16h,得一次放大菌液;(2) Primary amplification of strains: inoculate the activated strain into a new culture medium, YPD Broth, and culture at 24±2℃ for 10-16h to obtain a primary amplification bacterial solution;
(3)菌种二次放大:将一次放大菌液接种于第一培养基中,于24±2℃培养10-16h,得酵母菌菌液B;(3) Secondary amplification of the strain: inoculate the first amplified bacterial solution into the first culture medium and culture at 24±2°C for 10-16 h to obtain yeast culture solution B;
益生菌菌液制备过程如下:The preparation process of probiotic liquid is as follows:
(1)活化菌株:将益生菌菌株嗜酸乳杆菌(Lactobacillus acidophilus)、保加利亚乳杆菌(Lactobacillus bulgaricus)、德氏乳杆菌亚种(Lactobacillus delbrueckiisubsp.lactis)、罗伊氏乳杆菌(Lactobacillus reuteri)、短乳杆菌(Lactobacillusbrevis)、干酪乳杆菌(Lactobacillus casei)以及发酵乳杆菌(Lactobacillusfermentum)分别接种于第二培养基中,在37±2℃活化培养36-48h,制得活化菌株;(1) Activating strains: Probiotic strains Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus delbrueckii subsp. lactis, Lactobacillus reuteri, Lactobacillus brevis, Lactobacillus casei and Lactobacillus fermentum are inoculated into a second culture medium, respectively, and activated and cultured at 37±2° C. for 36-48 hours to obtain activated strains;
(2)菌种放大:将7种活化后的菌株混合后接种于第一培养基中,在37±2℃放大培养18-24h,得益生菌菌液。(2) Strain amplification: The seven activated strains were mixed and inoculated into the first culture medium, and cultured at 37±2°C for 18-24 hours to obtain a probiotic bacterial liquid.
所述方法还包括灭菌,即将发酵液过滤后进行灭菌,即得产品;所述灭菌方法如下:将滤液在137±5℃超高温下瞬间灭菌15秒后,利用利乐包进行包装,即得成品。或将滤液在低温85℃灭菌45分钟,再充填进易拉罐内,然后置于高温高压杀菌釜中,115±5℃下灭菌15分钟,即得成品。The method also includes sterilization, that is, sterilizing the fermentation liquid after filtering, so as to obtain the product; the sterilization method is as follows: sterilize the filtrate at ultra-high temperature of 137±5℃ for 15 seconds, and then package it in a Tetra Pak package to obtain the finished product. Or sterilize the filtrate at low temperature of 85℃ for 45 minutes, then fill it into a can, and then place it in a high-temperature and high-pressure sterilizer, sterilize it at 115±5℃ for 15 minutes, and then obtain the finished product.
本发明还涉及上述的一种益生菌发酵杨梅饮料的制备方法,制备得到的杨梅饮料。The present invention also relates to a method for preparing the above-mentioned probiotic fermented bayberry beverage and the prepared bayberry beverage.
下表1为,所述酵母菌菌液A培养用的培养基YM组分:Table 1 below shows the components of the medium YM used to culture the yeast liquid A:
表1Table 1
下表2所述酵母菌菌液B培养用的培养基YPD组分:The components of the medium YPD used for culturing the yeast culture B described in Table 2 below:
表2Table 2
下表3为益生菌菌液培养用的第二培养基组分,pH值为6.2-6.5,且可根据需求添加琼脂粉每升15.0克:Table 3 below shows the components of the second culture medium for culturing probiotic liquid, with a pH value of 6.2-6.5, and 15.0 g of agar powder per liter can be added as required:
表3Table 3
本发明利用益生菌发酵产生的杨梅饮料含有丰富的短链脂肪酸(SCFA,每100ml杨梅饮料中含有0.4~1.2g短链脂肪酸):短链脂肪酸是一种容易挥发的脂肪酸,它是哺乳类肠道里的乳酸菌菌或酵母菌把膳食纤维、抗性淀粉等难以消化的食物发酵之后生成的一种脂肪酸。短链脂肪酸中又以醋酸、丙酸、丁酸为主,占了肠道内短链脂肪酸的83%。生成的短链脂肪酸会成为肠内益菌利用的来源,还会进入人体的血液循环,成为提供人体的能量来源,调节人体的机能。短链脂肪酸在肠道中能为大肠细胞提供能量、促进肠道细胞分化、维持健康肠道黏膜、促进肠道蠕动、抑制害菌及促进益菌生长等。对整体健康而言,短链脂肪酸有促进制造血清素、调节身体部分免疫细胞以达致抗炎、抗肿瘤及抗菌等效用。短链脂肪酸和大肠细胞也是有着紧密的关系。有研究发现,短链脂肪酸能透过调控细胞内活动及细胞表面蛋白,以达到抗癌功效,能重新激活大肠癌细胞上的GPR43蛋白,从而抑制肿瘤生长和诱发癌细胞死亡,有助降低患上大肠癌的风险。The bayberry beverage produced by the fermentation of probiotics of the present invention contains rich short-chain fatty acids (SCFA, 0.4-1.2g of short-chain fatty acids per 100ml of bayberry beverage): short-chain fatty acids are a type of volatile fatty acids, which are produced by lactic acid bacteria or yeast in the intestinal tract of mammals after fermenting indigestible foods such as dietary fiber and resistant starch. Acetic acid, propionic acid and butyric acid are the main short-chain fatty acids, accounting for 83% of the short-chain fatty acids in the intestine. The generated short-chain fatty acids will become a source of utilization for beneficial bacteria in the intestine, and will also enter the blood circulation of the human body, becoming a source of energy for the human body and regulating the functions of the human body. Short-chain fatty acids can provide energy for large intestine cells in the intestine, promote intestinal cell differentiation, maintain healthy intestinal mucosa, promote intestinal peristalsis, inhibit harmful bacteria and promote the growth of beneficial bacteria. For overall health, short-chain fatty acids have the effects of promoting the production of serotonin and regulating some immune cells in the body to achieve anti-inflammatory, anti-tumor and antibacterial effects. Short-chain fatty acids and large intestine cells are also closely related. Studies have found that short-chain fatty acids can achieve anti-cancer effects by regulating intracellular activities and cell surface proteins. They can reactivate the GPR43 protein on colorectal cancer cells, thereby inhibiting tumor growth and inducing cancer cell death, helping to reduce the risk of colorectal cancer.
在本发明方法中杨梅经由益生菌发酵可以增加酵素、类黄酮(含量是杨梅本身的1-2倍)、多酚(含量是杨梅本身的2-3倍)含量,提升其抗自由基、抗氧化能力。酵素在人体内主要的工作内容为:消化吸收与分解代谢,其主要功效为提高营养吸收速度及分解效率,使得消化过程更流畅,是人类维持生理机能不可或缺的物质。补充酵素,能让消化过程更加顺利,帮助身体保健。类黄酮为水溶性的物质,具有抗氧化、抗病毒、抗发炎的等作用。中医认为,此成份可补养气血;增强身体的免疫能力、抗老化的作用。还有活血的功效;可促进身体的微循环、血瘀、改善心血管的问题。以及具有清热解毒的作用、抗病毒、抗发炎的功效。多酚有助于降低血糖水平、有助于刺激胰岛素的分泌、提高葡萄糖耐受性和增加胰岛素敏感性,降低2型糖尿病风险。多酚也可以改善心脏健康,因为多酚的抗氧化特性,它有助于减少慢性炎症。多酚可以降低患血栓的风险,当血液中循环的血小板开始聚集在一起时,就会形成血栓。过度的血小板聚集可能会导致血栓,这可能会对健康产生负面影响,包括深静脉血栓、中风和肺栓塞。多酚有助于减少血小板的聚集。In the method of the present invention, the fermentation of bayberry with probiotics can increase the content of enzymes, flavonoids (the content is 1-2 times that of bayberry itself), and polyphenols (the content is 2-3 times that of bayberry itself), thereby improving its anti-free radical and anti-oxidation capabilities. The main work content of enzymes in the human body is digestion, absorption and decomposition. Its main function is to increase the speed of nutrient absorption and decomposition efficiency, making the digestion process smoother. It is an indispensable substance for humans to maintain physiological functions. Supplementing enzymes can make the digestion process smoother and help the body maintain health. Flavonoids are water-soluble substances with antioxidant, antiviral, and anti-inflammatory effects. Traditional Chinese medicine believes that this ingredient can nourish qi and blood; enhance the body's immune ability and anti-aging effects. It also has the effect of promoting blood circulation; it can promote the body's microcirculation, blood stasis, and improve cardiovascular problems. It also has the effect of clearing away heat and detoxification, antiviral, and anti-inflammatory effects. Polyphenols help lower blood sugar levels, help stimulate insulin secretion, improve glucose tolerance and increase insulin sensitivity, and reduce the risk of type 2 diabetes. Polyphenols may also improve heart health because of their antioxidant properties, which help reduce chronic inflammation. Polyphenols may reduce the risk of blood clots, which form when platelets circulating in the blood begin to clump together. Excessive platelet aggregation may lead to blood clots, which may have negative health consequences, including deep vein thrombosis, stroke, and pulmonary embolism. Polyphenols help reduce platelet aggregation.
本发明以杨梅鲜果为原料,利用益生菌和酵母发酵,完整保留杨梅的营养价值,且还具有以下优点:The invention uses fresh bayberry as raw material, utilizes probiotics and yeast for fermentation, and completely retains the nutritional value of bayberry, and also has the following advantages:
(1)不加防腐剂:利用益生菌产生的罗伊氏素、乳酸链球菌素(reuterin,lacticin/nisin)抑菌杀死有害菌,天然杨梅香气持久、色泽艳丽,不添加色素、不添加香精;口味口感佳,具有杨梅天然的有益成分。因为借助微生物发酵,产生更多有益于人体的物质(胺基酸、多酚、類黃酮、維生素、短鏈脂肪酸、有機酸、酵素),提升杨梅延伸的附加效果。提高农产品深加工,提供价美物廉、有益健康的饮料。(1) No preservatives: Reuterin and lacticin/nisin produced by probiotics are used to inhibit bacteria and kill harmful bacteria. The natural bayberry has a long-lasting aroma and bright color. No pigments or flavors are added. The taste is good and contains the natural beneficial ingredients of bayberry. Because of the fermentation of microorganisms, more substances beneficial to the human body (amino acids, polyphenols, flavonoids, vitamins, short-chain fatty acids, organic acids, enzymes) are produced, which enhances the additional effects of bayberry. Improve the deep processing of agricultural products and provide affordable and healthy beverages.
(2)本发发明采用的酵母菌为单细胞的真核生物,属于兼性厌氧生物。根据环境中氧气浓度决定要进行二次代谢路径为有氧呼吸或是发酵作用。酵母菌使用糖解作用生产的ATP来发酵糖类,产生酒精与二氧化碳,反应式如下:(2) The yeast used in the present invention is a single-cell eukaryotic organism, which is a facultative anaerobic organism. The secondary metabolic pathway to be carried out is determined by the oxygen concentration in the environment, which is aerobic respiration or fermentation. Yeast uses ATP produced by glycolysis to ferment sugars to produce alcohol and carbon dioxide. The reaction formula is as follows:
C6H12O6→2C2H5OH+2CO2C6H12O6→2C2H5OH+2CO2
酵母菌里面有个机制,称为葡萄糖抑制作用,这个机制使得酵母菌在有葡萄糖存在的时候,只会使用葡萄糖;而在只有葡萄糖的状况下,又不提供氧气时,酵母菌为了生存下去,便会将丙酮酸还原,产生酒精和二氧化碳。There is a mechanism in yeast called glucose inhibition, which causes yeast to only use glucose when glucose is present. When there is only glucose and no oxygen is provided, yeast will reduce pyruvate to produce alcohol and carbon dioxide in order to survive.
本专利选取产生提升水果香味/香气的酵母菌进行发酵,利用能产生细菌素酶即罗伊氏素的益生菌(罗伊氏乳杆菌),控制酵母菌发酵不产酒。另外,益生菌的选择使得本发明产品具有以下特点:(1)风味优良,(2)能产生乳酸菌细菌素即罗伊氏素、乳酸链球菌素(reuterin,lacticin/nisin)(3)绝对同型发酵的乳酸杆菌属(Lactobacillus)乳酸菌,(4)以杨梅为原料,藉由酵母菌、益生菌发酵产生风味、口感更佳,具有天然有机酸、微生物代谢产生的有机酸,得到酸酸甜甜美味,口感俱佳。益生菌产生的乳酸细菌素(reuterin,lacticin/nisin)保护杨梅饮料,延长保存期至1-5年,达到不加香精、香料、防腐剂,适口性优良的饮料。This patent selects yeast that produces fruit flavor/aroma for fermentation, and uses probiotics (Lactobacillus reuteri) that can produce bacteriocin enzymes, namely reuterin, to control yeast fermentation and prevent wine production. In addition, the selection of probiotics makes the product of the present invention have the following characteristics: (1) excellent flavor, (2) can produce lactic acid bacteria bacteriocin, namely reuterin and nisin (reuterin, lacticin/nisin) (3) absolutely homotypic lactic acid bacteria of the genus Lactobacillus (Lactobacillus), (4) using bayberry as raw material, fermented by yeast and probiotics to produce flavor and taste better, with natural organic acids and organic acids produced by microbial metabolism, to obtain a sour and sweet taste with excellent taste. The lactic acid bacteriocin (reuterin, lacticin/nisin) produced by the probiotics protects the bayberry beverage and extends the shelf life to 1-5 years, achieving a beverage with excellent palatability without adding flavors, spices, or preservatives.
虽然以上描述了本发明的具体实施方式,但是熟悉本技术领域的技术人员应当理解,我们所描述的具体的实施例只是说明性的,而不是用于对本发明的范围的限定,熟悉本领域的技术人员在依照本发明的精神所作的等效的修饰以及变化,都应当涵盖在本发明的权利要求所保护的范围内。Although the specific implementation modes of the present invention are described above, those skilled in the art should understand that the specific implementation modes described are only illustrative and are not intended to limit the scope of the present invention. Equivalent modifications and changes made by those skilled in the art in accordance with the spirit of the present invention should be included in the scope of protection of the claims of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211149768.6A CN116076638A (en) | 2022-09-21 | 2022-09-21 | A kind of preparation method and product thereof of probiotic fermented bayberry beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211149768.6A CN116076638A (en) | 2022-09-21 | 2022-09-21 | A kind of preparation method and product thereof of probiotic fermented bayberry beverage |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116076638A true CN116076638A (en) | 2023-05-09 |
Family
ID=86212573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211149768.6A Pending CN116076638A (en) | 2022-09-21 | 2022-09-21 | A kind of preparation method and product thereof of probiotic fermented bayberry beverage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116076638A (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092593A (en) * | 2006-06-21 | 2007-12-26 | 郑建玮 | How to make mulberry red wine |
US20130295226A1 (en) * | 2011-01-21 | 2013-11-07 | Chr. Hansen A/S | Probiotics in fruit beverages |
US20130302454A1 (en) * | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution Llc. | Method for preparing fermentation broth of fruits and vegetables |
CN104939073A (en) * | 2015-05-22 | 2015-09-30 | 杜雪梅 | Waxberry ferment stock solution and preparation method thereof |
CN107821898A (en) * | 2017-12-11 | 2018-03-23 | 嘉兴佳康丽生物科技有限公司 | A kind of active probiotic pectase beverage and preparation method thereof |
CN110024931A (en) * | 2019-05-07 | 2019-07-19 | 贵阳学院 | A kind of preparation method of red bayberry fermented beverage |
CN111345416A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of mulberry enzyme beverage |
CN111345417A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of fig enzyme beverage |
-
2022
- 2022-09-21 CN CN202211149768.6A patent/CN116076638A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092593A (en) * | 2006-06-21 | 2007-12-26 | 郑建玮 | How to make mulberry red wine |
US20130295226A1 (en) * | 2011-01-21 | 2013-11-07 | Chr. Hansen A/S | Probiotics in fruit beverages |
US20130302454A1 (en) * | 2011-01-21 | 2013-11-14 | Jilin Zixin Pharmaceutical Research Institution Llc. | Method for preparing fermentation broth of fruits and vegetables |
CN104939073A (en) * | 2015-05-22 | 2015-09-30 | 杜雪梅 | Waxberry ferment stock solution and preparation method thereof |
CN107821898A (en) * | 2017-12-11 | 2018-03-23 | 嘉兴佳康丽生物科技有限公司 | A kind of active probiotic pectase beverage and preparation method thereof |
CN110024931A (en) * | 2019-05-07 | 2019-07-19 | 贵阳学院 | A kind of preparation method of red bayberry fermented beverage |
CN111345416A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of mulberry enzyme beverage |
CN111345417A (en) * | 2020-03-10 | 2020-06-30 | 安徽新天生物科技有限公司 | Preparation method of fig enzyme beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105249100B (en) | The production method of fermented fruits and vegetables juice and fermented glutinous rice beverage with compound functions | |
CN105815718A (en) | Fermented fruit and vegetable jam and preparation method thereof | |
CN107568537A (en) | A kind of compound microorganism ferments beverage containing anthocyanidin and preparation method thereof | |
CN104856153B (en) | Composite blueberry purple potato black kerneled rice lactic acid beverage and preparation method thereof | |
CN111066989A (en) | Compound beverage and preparation method thereof | |
CN104305427A (en) | Grape and red tea fungus drink | |
CN111248384A (en) | Composite probiotic enzyme beverage and preparation method thereof | |
CN110169545A (en) | A method of fermentation duck is prepared using lactic acid bacteria | |
CN106261368B (en) | A kind of preparation method of Huyou probiotic beverage | |
CN103431467A (en) | Asparagus extract bifidobacterium fermentation activity beverage and preparation method thereof | |
CN107173656A (en) | A kind of Chinese medicine fruits and vegetables probiotics fermented beverage and preparation method thereof | |
CN105852011A (en) | Method for preparing lotus seed functional fermented food | |
CN103798494B (en) | Stomach invigorating benefit spleen fermented tea haw jelly and preparation method thereof | |
KR20230037529A (en) | Preparation method of ingredients powder fermented by lactic acid bacteria | |
CN111418746A (en) | Pumpkin and apple compound fermented beverage and preparation method and application thereof | |
CN104382129A (en) | Beverage prepared from sweet corn and black tea fungus | |
CN104273613A (en) | Mango tea fungus drink | |
CN106360683A (en) | Dendrobium officinale and banana compound probiotic fermentation products and method thereof | |
CN103039845A (en) | Fermented black corn food and preparation method thereof | |
CN105942087A (en) | Preparation method of potato lactic acid fermentation prebiotic beverage | |
CN105802876A (en) | Composite probiotic-fermented alfalfa sprout powder preparation and preparation method and application thereof | |
CN108887680A (en) | A kind of efficient small molecule nutritional preparation and preparation method thereof for promoting intestinal beneficial bacterium proliferation | |
CN113208077A (en) | Preparation method of probiotic medlar vinegar jelly | |
CN105918961A (en) | Preparation method of taro functional fermented food | |
CN105982108B (en) | Carrot juice beverage and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20250108 Address after: Room 303, No. 43, Guoqing Road, Jing'an District, Shanghai, 200000 Applicant after: Shanghai Shengyongyuan Biotechnology Co.,Ltd. Country or region after: China Address before: 1st Floor, Building 12, Area C, Fuzhou Software Park, No. 89, Software Avenue, Gulou District, Fuzhou City, Fujian Province, 350000 Applicant before: Fujian Chengniang Biotechnology Co.,Ltd. Country or region before: China Applicant before: Chen Haowei Country or region before: TaiWan, China |
|
TA01 | Transfer of patent application right |